| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $1.45 (Beat by $0.07) |
| EPS GAAP Actual | $1.45 (Beat by $0.07) |
| Revenue Actual | $3.70805B |
| Revenue Surprise | Beat by $3708.05M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 7.56 | 22.38 | 7.44198 | 7.74155 | 1 |
| Dec 2027 | 6.96 | 24.31 | 6.85134 | 7.12715 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.11 | 1.11 | 3.70805B | 36.93% | 3708.05M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 2.40706B | 6.62% | 2407.06M |
| FQ1 2025 (Mar 2025) | 0.94 | 0.94 | 2.22818B | 6.98% | 2228.18M |
| FQ4 2024 (Dec 2024) | -0.76 | -0.76 | 2.26028B | 9.94% | 2260.28M |
| FQ3 2024 (Sep 2024) | 1.194 | 1.194 | 2.33849B | 11.71% | 2338.49M |
| FQ2 2024 (Jun 2024) | 1.07 | 1.07 | 2.2477B | 10.08% | 2247.7M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 2.07265B | 8.31% | 2072.65M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 2.03561B | 8.17% | 2035.61M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2030 (Sep 2030) | 2.29623 | -- | 2.26649 | 2.33434 | 4 |
| FQ2 2030 (Jun 2030) | 2.17772 | -- | 2.14951 | 2.21387 | 8 |
| FQ1 2030 (Mar 2030) | 2.02874 | -- | 2.00246 | 2.06241 | 5 |
| FQ4 2029 (Dec 2029) | 2.06763 | -- | 2.04092 | 2.1068 | 9 |
| FQ3 2029 (Sep 2029) | 2.13559 | -- | 2.108 | 2.17605 | 9 |
| FQ2 2029 (Jun 2029) | 2.023 | -- | 1.99686 | 2.06133 | 9 |
| FQ1 2029 (Mar 2029) | 1.86759 | -- | 1.84346 | 1.90297 | 9 |
| FQ4 2028 (Dec 2028) | 1.73366 | -- | 1.71126 | 1.76651 | 6 |
| FQ3 2028 (Sep 2028) | 1.851 | -- | 1.82709 | 1.88607 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2030 (Sep 2030) | 4.56B | -- | 4.51B | 4.62B | 5 |
| FQ2 2030 (Jun 2030) | 4.42B | -- | 4.38B | 4.48B | 5 |
| FQ1 2030 (Mar 2030) | 4.29B | -- | 4.24B | 4.34B | 5 |
| FQ4 2029 (Dec 2029) | 4.16B | -- | 4.12B | 4.22B | 5 |
| FQ3 2029 (Sep 2029) | 4.03B | -- | 3.99B | 4.09B | 5 |
| FQ2 2029 (Jun 2029) | 3.91B | -- | 3.87B | 3.96B | 5 |
| FQ1 2029 (Mar 2029) | 3.79B | -- | 3.75B | 3.84B | 5 |
| FQ4 2028 (Dec 2028) | 2.82B | -- | 2.79B | 2.86B | 4 |
| FQ3 2028 (Sep 2028) | 2.88B | -- | 2.85B | 2.92B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.11 | 1.11 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 0.94 | 0.94 | 100% | |
| FQ4 2024 (Dec 2024) | -0.76 | -0.76 | 100% | |
| FQ3 2024 (Sep 2024) | 1.194 | 1.194 | 100% | |
| FQ2 2024 (Jun 2024) | 1.07 | 1.07 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $3.71B | $3708.05M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.41B | $2407.06M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.23B | $2228.18M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.26B | $2260.28M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.34B | $2338.49M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.25B | $2247.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.07B | $2072.65M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.04B | $2035.61M | 100% |